Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13

Trial Status

Recruiting1
Other2

Role Distribution

Principal Investigator1
Other Roles2
PI Rate33%

Activity Timeline

Clinical Trials (3)

NCT05768880Phase 1Active Not Recruiting
Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors
Diffuse Intrinsic Pontine GliomaDiffuse Midline GliomaRecurrent CNS Tumor, Adult+2 more
PrincipalinvestigatorStart date: 2023-05-05
NCT04185038Phase 1Recruiting
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Atypical Teratoid/Rhabdoid TumorCentral Nervous System TumorChoroid Plexus Carcinoma+8 more
StudychairStart date: 2019-12-11
NCT03500991Phase 1Active Not Recruiting
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
Atypical Teratoid/Rhabdoid TumorCentral Nervous System Tumor, PediatricChoroid Plexus Carcinoma+6 more
StudychairStart date: 2018-07-26

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sabine Mueller, MD, PhD, MAS

University of California, San Francisco

Related
10 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaGliomaAtypical Teratoid/Rhabdoid Tumor+3 more
Similarity Score11%

John W Glod, M.D.

National Cancer Institute (NCI)

Related
8 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaEpendymomaMedulloblastoma+1 more
Similarity Score7%

Giselle Sholler, MD

Beat Childhood Cancer at Atrium Health

Related
10 trials

Shared therapeutic areas:

MedulloblastomaEpendymomaNeoplasms, Germ Cell+1 more
Similarity Score7%

Katherine E Warren, M.D.

National Cancer Institute (NCI)

Related
8 trials

Shared therapeutic areas:

EpendymomaNeuroectodermal Tumors, PrimitiveGlioma+1 more
Similarity Score7%

Amar Gajjar, MD

St. Jude Children's Research Hospital

Related
10 trials

Shared therapeutic areas:

Atypical Teratoid/Rhabdoid TumorCentral Nervous System NeoplasmsMedulloblastoma
Similarity Score5%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaEpendymomaNeuroectodermal Tumors, Primitive
Similarity Score5%

Daniel Landi, MD

Duke University

Related
7 trials

Shared therapeutic areas:

EpendymomaGliomaMedulloblastoma
Similarity Score5%

Maryam Fouladi, MD

Nationwide Children's Hospital

Related
10 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaMedulloblastoma
Similarity Score4%

AeRang Kim, MD, PhD

Children's National Research Institute

Related
7 trials

Shared therapeutic areas:

Neoplasms, Germ Cell
Similarity Score2%

Mia Weiss, M.D.

Washington University School of Medicine

Related
5 trials

Shared therapeutic areas:

Medulloblastoma
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05768880Phase 1PrincipalInvestigator

Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors

Diffuse Intrinsic Pontine GliomaDiffuse Midline GliomaRecurrent CNS Tumor, Adult+2 more
Active Not Recruiting
NCT04185038Phase 1StudyChair

Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors

Atypical Teratoid/Rhabdoid TumorCentral Nervous System TumorChoroid Plexus Carcinoma+8 more
Recruiting
NCT03500991Phase 1StudyChair

HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors

Atypical Teratoid/Rhabdoid TumorCentral Nervous System Tumor, PediatricChoroid Plexus Carcinoma+6 more
Active Not Recruiting

All 3 trials loaded